ARL8B and Alzheimer disease: Interestingly, our investigations indicate that Arl8b protein levels are significantly increased both in CSF and postmortem brain tissues of AD patients (Fig. 6a–d), suggesting that this protein may have the potential to be utilized as a biomarker to monitor lysosomal function or dysfunction in AD brains.